Koninklijke Philips Revenue 2010-2022 | PHG

Koninklijke Philips annual/quarterly revenue history and growth rate from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Koninklijke Philips revenue for the quarter ending September 30, 2022 was $4.341B, a 17.32% decline year-over-year.
  • Koninklijke Philips revenue for the twelve months ending September 30, 2022 was $18.722B, a 18.35% decline year-over-year.
  • Koninklijke Philips annual revenue for 2022 was $18.783B, a 7.46% decline from 2021.
  • Koninklijke Philips annual revenue for 2021 was $20.297B, a 9.04% decline from 2020.
  • Koninklijke Philips annual revenue for 2020 was $22.315B, a 2.27% increase from 2019.
Koninklijke Philips Annual Revenue
(Millions of US $)
2022 $18,783
2021 $20,297
2020 $22,315
2019 $21,820
2018 $21,401
2017 $20,097
2016 $27,129
2015 $26,921
2014 $28,435
2013 $30,988
2012 $31,880
2011 $31,448
2010 $33,756
2009 $32,339
Koninklijke Philips Quarterly Revenue
(Millions of US $)
2022-09-30 $4,341
2022-06-30 $4,445
2021-06-30 $5,097
2020-06-30 $4,839
2019-06-30 $5,250
2018-06-30 $5,114
2017-06-30 $4,724
2016-12-31 $7,842
2016-09-30 $6,579
2016-06-30 $6,622
2016-03-31 $6,086
2015-12-31 $7,793
2015-09-30 $6,493
2015-06-30 $6,608
2015-03-31 $6,026
2014-12-31 $6,934
2014-09-30 $7,360
2014-06-30 $7,261
2014-03-31 $6,880
2013-12-31 $9,217
2013-09-30 $7,442
2013-06-30 $7,384
2013-03-31 $6,945
2012-12-31 $9,640
2012-09-30 $7,995
2012-06-30 $7,188
2012-03-31 $7,364
2011-12-31 $8,799
2011-09-30 $7,447
2011-06-30 $7,502
2011-03-31 $7,583
2010-12-31 $10,061
2010-09-30 $7,945
2010-06-30 $7,900
2010-03-31 $7,868
2009-12-31 $10,727
2009-09-30 $8,108
2009-06-30 $7,441
2009-03-31 $6,638
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.021B $18.786B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $171.396B 18.47
Stryker (SYK) United States $105.786B 29.88
Medtronic (MDT) Ireland $105.197B 15.06
Boston Scientific (BSX) United States $70.544B 28.70
ResMed (RMD) United States $31.368B 35.71
Zimmer Biomet Holdings (ZBH) United States $26.486B 18.40
Baxter (BAX) United States $20.494B 11.58
Bio-Rad Laboratories (BIO) United States $13.968B 33.17
Smith & Nephew SNATS (SNN) United Kingdom $12.105B 0.00
Envista Holdings (NVST) United States $6.408B 20.24
Perrigo (PRGO) Ireland $4.742B 16.96
BellRing Brands (BRBR) United States $4.409B 27.98
Haemonetics (HAE) United States $4.011B 27.32
Owens & Minor (OMI) United States $1.041B 5.66
Warby Parker (WRBY) United States $0.984B 0.00
Zevia PBC (ZVIA) United States $0.253B 0.00
Vapotherm (VAPO) United States $0.027B 0.00